Research
Read how they describe their research on their Université Laval profile.
Latest funding
- $225,592
Élaboration d'un procédé de production de cellules thérapeutiques autologues destiné au traitement de la Dystrophie musculaire de Duchenne
CIHR · 2013 · Co-investigator
No publications available.
Élaboration d'un procédé de production de cellules thérapeutiques autologues destiné au traitement de la Dystrophie musculaire de Duchenne
Principal investigators: Gaillet, Bruno; Tremblay, Jacques P
Keywords: Cellules Souches Pluripotentes Induites; Dystrophie Musculaire De Duchenne; Développement De Milieux De Culture; Génie Biochimique 1802; Particules Pseudo Virales; Produits Pharmaceutiques Administrables À L'Homme 504; Sciences De La Santé 9000; Sciences De La Vie (Y Compris Biotechnologie) 1201; Thérapie Cellulaire; Transfection De Protéines
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.